REVELATION BIOSCIENCES, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-3.3M | $-3.0M | $-1.9M | $-2.4M | $-2.1M | $-2.2M | $-8.4M | $-2.7M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $8.3K | $7.2K | — | $7.2K | $7.2K | $7.2K | $7.2K | $6.3K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $471.0K | — | — | $223.5K | — | — | $32.1K |
| Net Cash from Operating Activities | — | $-3.2M | — | — | $-2.8M | — | — | $-2.8M |
| Investing Activities | ||||||||
| Capital Expenditures | — | $71.9K | — | — | — | — | — | $19.2K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $-71.9K | — | — | — | — | — | $-19.2K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $6.7M | — | — | — | — | — | $5.4M |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | — | $-3.3M | — | — | — | — | — | $-2.9M |